On the need for objective measures of risk of bias

Contemporary Clinical Trials

Volumn 41, Issue , 2015, Pages 202-203

  Berger, Vance W ^a   Mickenautsch, Steffen ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Objective measures; Randomized trials; Risk of bias

Indexed keywords

EVALUATION STUDY; EXTERNAL VALIDITY; LETTER; MASKING; RELIABILITY; RISK; RISK OF BIAS; SELECTION BIAS; STATISTICAL BIAS; DOUBLE BLIND PROCEDURE; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SINGLE BLIND PROCEDURE;

BIAS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; RISK ASSESSMENT; SINGLE-BLIND METHOD;

EID: 84922466214     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.02.001     Document Type: Letter

References (9)

1. Armijo-Olivo S., Ospina M., da Costa B.R., Eggers M., Saltaji H., Fuentes J., et al. Poor reliability between cochrane reviewers and blinded external reviewers when applying the cochrane risk of bias tool in physical therapy trials. PLoS One 2014, 9:e96920.
2. Berger V.W. Trials: the worst possible design (except for all the rest). Int J Pers Cent Med 2011, 1:630-631.
3. Berger V.W., Alperson S.Y. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials 2009, 4:79-88.
4. Berger V.W., Exner D.V. Detecting selection bias in randomized clinical trials. Control Clin Trials 1999, 20:319-327.
5. Higgins J.P., Altman D.G., Gøtzsche P.C., Jüni P., Moher D., Oxman A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
6. Mickenautsch S., Fu B., Gudehithlu S., Berger V.W. Accuracy of the Berger-Exner test for detecting third-order selection bias in randomised controlled trials: a simulation-based investigation. BMC Med Res Methodol 2014, 14:114.
7. Berger V.W. Selection bias and covariate imbalances in randomized clinical trials 2005, John Wiley & Sons, Chichester.
8. Berger V.W. Pros and cons of permutation tests in clinical trials. Stat Med 2000, 19:1319-1328.
9. Berger V.W., Rezvani A., Makarewicz V. Direct effect on validity of response run-in selection in clinical trials. Control Clin Trials 2003, 24:156-166.